Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI-net).

Autor: Ring K; Barts Health NHS Trust, London, UK.; Queen Mary University of London, London, UK., Smuk M; Queen Mary University of London, London, UK., Shongwe M; Barts Health NHS Trust, London, UK., Okonta L; Barts Health NHS Trust, London, UK., Mackie NE; Imperial College Healthcare NHS Trust, London, UK., Ayres S; Imperial College Healthcare NHS Trust, London, UK., Barber TJ; Royal Free London NHS Foundation Trust, London, UK.; Institute for Global Health, UCL, London, UK., Akodu J; Royal Free London NHS Foundation Trust, London, UK., Ferro F; Royal Free London NHS Foundation Trust, London, UK., Chilton D; Guy's and St Thomas' NHS Foundation Trust, London, UK., Hurn E; Guy's and St Thomas' NHS Foundation Trust, London, UK., Halai B; Guy's and St Thomas' NHS Foundation Trust, London, UK., Barchi W; Guy's and St Thomas' NHS Foundation Trust, London, UK., Ali A; Guy's and St Thomas' NHS Foundation Trust, London, UK., Darko S; Guy's and St Thomas' NHS Foundation Trust, London, UK., White G; Guy's and St Thomas' NHS Foundation Trust, London, UK., Clarke E; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Clark F; Cardiff and Vale University Health Board, Cardiff, UK., Ali B; Cardiff and Vale University Health Board, Cardiff, UK., Arumainayagam J; Walsall Healthcare NHS Trust, Walsall, UK., Quinn G; Walsall Healthcare NHS Trust, Walsall, UK., Boffito M; Chelsea and Westminster Hospital NHS Foundation Trust, London, UK., Byrne R; Chelsea and Westminster Hospital NHS Foundation Trust, London, UK., Naous N; Chelsea and Westminster Hospital NHS Foundation Trust, London, UK., Leung S; Chelsea and Westminster Hospital NHS Foundation Trust, London, UK., Umaipalan A; Barking, Havering and Redbridge University Hospitals NHS Trust, Romford, UK., Thornton B; Barking, Havering and Redbridge University Hospitals NHS Trust, Romford, UK., Bayliss D; Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, UK., McLoughlin C; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK., Foster J; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK., Waters L; Central and North West London NHS Foundation Trust, London, UK., Orkin C; Barts Health NHS Trust, London, UK.; Queen Mary University of London, London, UK.

Publikováno v: HIV medicine [HIV Med] 2024 Oct; Vol. 25 (10), pp. 1125-1134. Date of Electronic Publication: 2024 Jun 10.

Perspectives of people with HIV on implementing long acting cabotegravir plus rilpivirine in clinics and community settings in the UK: results from the anti-sexist, anti-racist, anti-ageist ILANA study.

Autor: Orkin C; SHARE Collaborative, Blizard Institute, Queen Mary University of London, London, United Kingdom.; Barts Health NHS Trust, London, United Kingdom., Hayes R; SHARE Collaborative, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom., Haviland J; Pragmatic Clinical Trials Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom., Wong YL; Pragmatic Clinical Trials Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom., Ring K; SHARE Collaborative, Blizard Institute, Queen Mary University of London, London, United Kingdom.; Barts Health NHS Trust, London, United Kingdom., Apea V; Barts Health NHS Trust, London, United Kingdom.; SHARE Collaborative, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom., Kasadha B; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom., Clarke E; Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom., Byrne R; Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom., Fox J; School of Immunology & Microbial Sciences, Kings College London, London, United Kingdom.; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Barber TJ; Royal Free London NHS Foundation Trust, London, United Kingdom.; Institute for Global Health, University College London, London, United Kingdom., Clarke A; University Hospitals Sussex NHS Foundation Trust, Brighton, United Kingdom., Paparini S; SHARE Collaborative, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Oct 28. Date of Electronic Publication: 2024 Oct 28.

Co-creating a Mpox Elimination Campaign in the WHO European Region: The Central Role of Affected Communities.

Autor: Palumbo L; Risk Communication, Community Engagement, and Infodemic Management Unit, World Health Organization European Regional Office, Copenhagen, Denmark., Picchio CA; Risk Communication, Community Engagement, and Infodemic Management Unit, World Health Organization European Regional Office, Copenhagen, Denmark., Barbier F; AIDES, Paris, France., Calderon-Cifuentes A; Research Team, Transgender Europe, Berlin, Germany., James J; European Sex Worker Rights Alliance, Amsterdam, The Netherlands., Lunchenkov N; Health and Capacity Building Department, Eurasian Coalition on Health, Rights, Gender, and Sexual Diversity, Tallinn, Estonia.; School of Social Sciences and Technology, Technical University of Munich, Munich, Germany., Nutland W; The Love Tank, London, United Kingdom., Owen G; PrEP Team, Terrence Higgins Trust, London, United Kingdom., Orkin C; SHARE Collaborative, Blizard Institute, Queen Mary University of London, London, United Kingdom., Rocha M; Grupo de Ativistas em Tratamentos, Lisbon, Portugal., Shanley A; MPOWER Programme, HIV Ireland, Dublin, Ireland., Stevenson L; European Sex Worker Rights Alliance, Amsterdam, The Netherlands., Vinti P; Joint Infectious Diseases Unit, World Health Organization European Regional Office, Copenhagen, Denmark., Salvi C; Risk Communication, Community Engagement, and Infodemic Management Unit, World Health Organization European Regional Office, Copenhagen, Denmark.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2024 Sep 24; Vol. 11 (10), pp. ofae523. Date of Electronic Publication: 2024 Sep 24 (Print Publication: 2024).

Gender and ethnicity intersect to reduce participation at a large European hybrid HIV conference.

Autor: Howe A; SHARE collaborative, Wolfson Institute of Population Health, Queen Mary University of London, London, UK., Wan YI; Adult Critical Care Research Unit, Barts Health NHS Trust, London, UK.; William Harvey Research Institute, Queen Mary University of London, London, UK., Gilleece Y; Lawson Unit, Department of HIV Medicine, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK., Aebi-Popp K; Department of Infectious Diseases, University of Bern, Bern, Switzerland., Dhairyawan R; SHARE collaborative, Department of Immunobiology, Blizard Institute, Queen Mary University of London, London, UK.; Division of Infection and Immunity, Barts Health NHS Trust, London, UK., Bhagani S; Department of Infectious Diseases and HIV Medicine, Royal Free London NHS Trust, London, UK.; Division of Infection and Immunity, University College London, London, UK., Paparini S; SHARE collaborative, Wolfson Institute of Population Health, Queen Mary University of London, London, UK., Orkin C; SHARE collaborative, Department of Immunobiology, Blizard Institute, Queen Mary University of London, London, UK c.m.orkin@qmul.ac.uk.; Division of Infection and Immunity, Barts Health NHS Trust, London, UK.

Publikováno v: BMJ leader [BMJ Lead] 2024 Sep 18; Vol. 8 (3), pp. 227-233. Date of Electronic Publication: 2024 Sep 18.

MAVMET trial: maraviroc and/or metformin for metabolic dysfunction associated fatty liver disease in adults with suppressed HIV.

Autor: McCabe L; Medical Research Council Clinical Trials Unit at UCL, Institute for Clinical Trials and Methodology, University College London (UCL)., Burns JE; Institute for Global Health, UCL.; Mortimer Market Centre, Central and Northwest London NHS Foundation Trust., Latifoltojar A; UCL Centre for Medical Imaging, UCL., Post FA; King's College Hospital NHS Foundation Trust.; King's College London., Fox J; King's College London.; Guy's and St Thomas' NHS Foundation Trust., Pool E; Institute for Global Health, UCL.; Mortimer Market Centre, Central and Northwest London NHS Foundation Trust., Waters A; Guy's and St Thomas' NHS Foundation Trust., Santana B; King's College Hospital NHS Foundation Trust., Garvey L; Imperial College Healthcare NHS Trust., Johnson M; Royal Free London NHS Foundation Trust, London., McGuinness I; Imperial College Healthcare NHS Trust., Chouhan M; UCL Centre for Medical Imaging, UCL., Edwards J; Royal Free London NHS Foundation Trust, London., Goodman AL; Medical Research Council Clinical Trials Unit at UCL, Institute for Clinical Trials and Methodology, University College London (UCL).; Guy's and St Thomas' NHS Foundation Trust., Cooke G; Imperial College Healthcare NHS Trust.; University of Oxford, Oxford., Murphy C; Medical Research Council Clinical Trials Unit at UCL, Institute for Clinical Trials and Methodology, University College London (UCL)., Collaco-Moraes Y; Medical Research Council Clinical Trials Unit at UCL, Institute for Clinical Trials and Methodology, University College London (UCL)., Webb H; Medical Research Council Clinical Trials Unit at UCL, Institute for Clinical Trials and Methodology, University College London (UCL)., Gregory A; Medical Research Council Clinical Trials Unit at UCL, Institute for Clinical Trials and Methodology, University College London (UCL)., Mohamed F; Medical Research Council Clinical Trials Unit at UCL, Institute for Clinical Trials and Methodology, University College London (UCL)., Rauchenberger M; Medical Research Council Clinical Trials Unit at UCL, Institute for Clinical Trials and Methodology, University College London (UCL)., Ryder SD; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and The University of Nottingham, Nottingham, UK., Sandford C; Mortimer Market Centre, Central and Northwest London NHS Foundation Trust., Baker JV; Hennepin Healthcare Research Institute, Minneapolis, Minnesota, USA., Angus B; University of Oxford, Oxford., Boesecke C; University of Bonn, Bonn, Germany., Orkin C; Royal London Hospital, Barts Health NHS Trust.; Queen Mary University of London., Punwani S; UCL Centre for Medical Imaging, UCL., Clark A; ViiV Healthcare, London, UK., Gilson R; Institute for Global Health, UCL.; Mortimer Market Centre, Central and Northwest London NHS Foundation Trust., Dunn D; Medical Research Council Clinical Trials Unit at UCL, Institute for Clinical Trials and Methodology, University College London (UCL)., Pett SL; Medical Research Council Clinical Trials Unit at UCL, Institute for Clinical Trials and Methodology, University College London (UCL).; Institute for Global Health, UCL.; Mortimer Market Centre, Central and Northwest London NHS Foundation Trust.

Publikováno v: AIDS (London, England) [AIDS] 2024 Aug 01; Vol. 38 (10), pp. 1513-1522. Date of Electronic Publication: 2024 Jun 25.